Sergio Traversa, CEO at RELMADA THERAPEUTICS, INC. (RLMD), sold 2,892 shares at $35.43 ($102K) on 2021-02-11, disclosed to the SEC on 2021-02-16.
Open-market sale of $102k RLMD by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.43 | 1,446 | $51K | 50.0% |
| 2 | $35.43 | 1,446 | $51K | 50.0% |
| Total | $35.43 avg | 2,892 | $102K | 100% |
| Filing → |
| RLMD | BUY | 2025-11-06 | $600K | — | Filing → |
| RLMD | BUY | 2025-08-28 | $265K | — | Filing → |
| RLMD | BUY | 2025-05-20 | $335K | — | Filing → |